Recent Advances in Clinical Biochemical Testing
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Laboratory Medicine".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 120
Special Issue Editor
Interests: endocrine biomarkers (thyroid disease, diabetes); cardiac biomarkers (troponin, BNP, Galactin3, Lipids); COVID19 biomarkers (antibodies, antigen); cancer biomarkers (HE4, circulating tumor cells); lab management (POCT, accreditation, LEAN)
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to provide a comprehensive overview of the latest developments and innovations in the field of clinical biochemical testing. This special issue will cover a wide range of topics related to the advancement of biochemical testing, including but not limited to novel biomarkers, advanced analytical techniques, and emerging technologies in the field of clinical biochemistry. The scope of this special issue encompasses research articles, review papers, and original studies that highlight the significant contributions and impact of biochemical testing on clinical diagnosis, disease monitoring, and personalized medicine.
The papers included in this special issue will provide valuable insights into the current state of the art in clinical biochemical testing and offer perspectives on future directions and potential applications in the field. Researchers, healthcare professionals, and industry experts are invited to contribute to this special issue to facilitate knowledge exchange and promote advancements in clinical biochemistry.
Dr. Aw Tar-Choon
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- clinical chemistry
- diagnostic testing
- biomarkers
- point-of-care testing
- mass spectrometry
- immunoassays
- microfluidics
